The overexpression of miR‐181a inhibits the expression of PTEN, resulting in an increase in phosphorylated AKT, which in turn triggers a metabolic shift and promotes cell proliferation in CRC [65]. This evidence concerns the gene AKT1 and colorectal carcinoma.